Aurobindo Accesses Russian OTC Market Through Deal With Diod
This article was originally published in The Tan Sheet
Indian company Aurobindo Pharma stakes a claim in Russia’s surging consumer health product market with a joint venture to market OTC and generic drugs.
You may also be interested in...
Central and Eastern Europe continue to drive OTC sales growth on the continent, with even low-growth countries matching the best levels in Western Europe.
Johnson & Johnson expands its consumer health presence in Russia and other Eastern European markets with the acquisition of several OTC brands from J.B. Chemicals & Pharmaceuticals.
Russia has called for half of all pharmaceuticals in the country to be produced domestically in the next decade, pledging to spend 122.9 billion rubles ($3.97 billion) to get international drug makers to shift drug production to the country and strengthen R&D collaboration